Joy Schechtman
About
In The Last Decade
Joy Schechtman
16 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Rheumatology 1.1k
- Immunology 533
- Hematology 421
- Radiology, Nuclear Medicine and Imaging 405
- Genetics 360
Countries citing papers authored by Joy Schechtman
This map shows the geographic impact of Joy Schechtman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Schechtman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Schechtman more than expected).
Fields of papers citing papers by Joy Schechtman
This network shows the impact of papers produced by Joy Schechtman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Schechtman. The network helps show where Joy Schechtman may publish in the future.
Co-authorship network of co-authors of Joy Schechtman
This figure shows the co-authorship network connecting the top 25 collaborators of Joy Schechtman. A scholar is included among the top collaborators of Joy Schechtman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy Schechtman. Joy Schechtman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 51 | |
| 6 | Synergistic effect of using a transcutaneous electrical joint stimulator and an unloading brace in treating osteoarthritis of the knee. | 3 |
| 7 | 5 | |
| 8 | 96 | |
| 9 | 157 | |
| 10 | The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis. | 115 |
| 11 | The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial breakdown → | 783 |
| 12 | Safety and tolerability of rituximab in patients with moderate to severe rheumatoid arthritis: Results from the dose-ranging assessment international clinical evaluation of rituximab in rheumatoid arthritis (DANCER) study | 12 |
| 13 | 66 | |
| 14 | Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis. | 29 |
| 15 | 292 | |
| 16 | 102 | |
| 17 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.